News

STAT12d
Inside the staff exodus and tanking morale that threaten Makary’s FDA
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
BioSpace2d
CDER Employees Leave FDA in Droves Amid HHS Overhaul
In the first 6 months of 2025, 385 employees resigned from the Center for Drug Evaluation and Research, compared with under ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
CBO finds health agency cuts would result in fewer new drugs
Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...
EPA eliminates research and development office, begins layoffs
The Environmental Protection Agency said Friday it is eliminating its research and development arm and reducing agency staff ...
BioSpace3d
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
H.H.S. Finalizes Thousands of Layoffs After Supreme Court Decision
The Department of Health and Human Services finalized the layoffs of thousands of employees after a Supreme Court ruling ...
Government Executive4d
Some agencies are walking back planned layoffs, Trump administration says
Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.
Becker's Hospital Review12d
Drug inspectors warn of slower checks following FDA layoffs
Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...
EconoTimes1d
Trump 2026 Budget Plan’s NIH Cuts Could Slow Drug Development, CBO Warns
The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...
FDA panel to revisit menopausal hormone therapy
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
STAT12d
Pharmalittle: We’re reading about FDA morale, a U.S.-Swiss trade deal on pharma levies, and more
The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits ...